Oxford Immunotec Global Plc (OXFD) Stock Value Rose While Tiverton Asset Management Cut Its Stake by $1.05 Million; Hd Supply Hldgs (HDS) Shareholder Mountain Pacific Investment Advisers Decreased Stake

June 16, 2018 - By Adrian Erickson

HD Supply Holdings, Inc. (NASDAQ:HDS) Logo

Mountain Pacific Investment Advisers Inc decreased its stake in Hd Supply Hldgs Inc (HDS) by 86.59% based on its latest 2018Q1 regulatory filing with the SEC. Mountain Pacific Investment Advisers Inc sold 228,358 shares as the company’s stock rose 9.48% while stock markets declined. The institutional investor held 35,355 shares of the consumer services company at the end of 2018Q1, valued at $1.34 million, down from 263,713 at the end of the previous reported quarter. Mountain Pacific Investment Advisers Inc who had been investing in Hd Supply Hldgs Inc for a number of months, seems to be less bullish one the $8.12B market cap company. The stock increased 2.15% or $0.93 during the last trading session, reaching $44.22. About 2.39M shares traded or 37.58% up from the average. HD Supply Holdings, Inc. (NASDAQ:HDS) has declined 2.18% since June 16, 2017 and is downtrending. It has underperformed by 14.75% the S&P500.

Tiverton Asset Management Llc decreased its stake in Oxford Immunotec Global Plc (OXFD) by 74.96% based on its latest 2018Q1 regulatory filing with the SEC. Tiverton Asset Management Llc sold 87,450 shares as the company’s stock rose 18.58% while stock markets declined. The institutional investor held 29,216 shares of the in vitro & in vivo diagnostic substances company at the end of 2018Q1, valued at $364,000, down from 116,666 at the end of the previous reported quarter. Tiverton Asset Management Llc who had been investing in Oxford Immunotec Global Plc for a number of months, seems to be less bullish one the $351.98M market cap company. The stock increased 1.04% or $0.14 during the last trading session, reaching $13.6. About 555,056 shares traded or 310.04% up from the average. Oxford Immunotec Global PLC (NASDAQ:OXFD) has risen 0.28% since June 16, 2017 and is uptrending. It has underperformed by 12.29% the S&P500. Some Historical OXFD News: 22/05/2018 – Oxford Immunotec Presenting at UBS Conference Tomorrow; 14/05/2018 – T Rowe Price Associates Exits Position in Oxford Immunotec; 01/05/2018 – Oxford Immunotec Global 1Q Loss/Shr 40c; 06/03/2018 – U.S. FDA SAYS APPROVAL OF THE IMUGEN BABESIA MICROTI AFIA AND NAT TESTS WAS GRANTED TO OXFORD IMMUNOTEC INC; 01/05/2018 – Oxford Immunotec Global 1Q Loss $10.3M; 06/03/2018 FDA APPROVES OXFORD IMMUNOTEC TESTS FOR BLOOD, PLASMA; 16/05/2018 – Oxford Immunotec Presenting at UBS Conference May 23; 14/05/2018 – Broadfin Capital Buys New 1.4% Position in Oxford Immunotec; 15/03/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within Marlin Business Services, Oxford Immunotec Global, Teck Res; 01/05/2018 – Oxford Immunotec Global Adjusts 2018 View To Rev $112M-$115M

Another recent and important HD Supply Holdings, Inc. (NASDAQ:HDS) news was published by Livetradingnews.com which published an article titled: “HD Supply Holdings, Inc. (NASDAQ:HDS) Exit at $44.82” on June 06, 2018.

Among 19 analysts covering HD Supply Holdings (NASDAQ:HDS), 9 have Buy rating, 0 Sell and 10 Hold. Therefore 47% are positive. HD Supply Holdings had 60 analyst reports since July 30, 2015 according to SRatingsIntel. Morgan Stanley upgraded the shares of HDS in report on Tuesday, December 20 to “Overweight” rating. The company was maintained on Wednesday, December 9 by Susquehanna. The stock of HD Supply Holdings, Inc. (NASDAQ:HDS) has “Outperform” rating given on Thursday, December 10 by Credit Suisse. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, September 10. Susquehanna maintained the stock with “Hold” rating in Wednesday, March 14 report. The rating was maintained by RBC Capital Markets on Tuesday, March 13 with “Hold”. The rating was downgraded by Morgan Stanley to “Hold” on Wednesday, June 7. Wells Fargo maintained the stock with “Outperform” rating in Friday, October 6 report. Drexel Hamilton downgraded the stock to “Hold” rating in Wednesday, June 7 report. The company was maintained on Wednesday, December 9 by RBC Capital Markets.

Investors sentiment decreased to 1.11 in Q1 2018. Its down 0.10, from 1.21 in 2017Q4. It turned negative, as 41 investors sold HDS shares while 95 reduced holdings. 37 funds opened positions while 114 raised stakes. 174.66 million shares or 0.38% less from 175.32 million shares in 2017Q4 were reported. First Republic Invest Management has 0.06% invested in HD Supply Holdings, Inc. (NASDAQ:HDS) for 187,605 shares. Vanguard Group Inc Inc has invested 0.03% of its portfolio in HD Supply Holdings, Inc. (NASDAQ:HDS). Carroll Financial Assocs owns 20 shares. Deutsche Bancorporation Ag reported 1.11M shares. Strs Ohio owns 0% invested in HD Supply Holdings, Inc. (NASDAQ:HDS) for 2,554 shares. Jpmorgan Chase And Co invested 0% of its portfolio in HD Supply Holdings, Inc. (NASDAQ:HDS). Clinton Grp reported 160,182 shares. Daiwa Group reported 5,900 shares or 0% of all its holdings. Moneta Gru Investment Advisors Limited has invested 0.03% in HD Supply Holdings, Inc. (NASDAQ:HDS). Mrj stated it has 2.32% in HD Supply Holdings, Inc. (NASDAQ:HDS). Gabelli Funds Ltd Llc stated it has 0.02% in HD Supply Holdings, Inc. (NASDAQ:HDS). Renaissance Limited Liability invested in 621,100 shares. Massachusetts Fincl Services Ma has invested 0.13% of its portfolio in HD Supply Holdings, Inc. (NASDAQ:HDS). 1,925 are held by Benjamin F Edwards And Co. Northern Corp reported 0.01% of its portfolio in HD Supply Holdings, Inc. (NASDAQ:HDS).

More notable recent Oxford Immunotec Global PLC (NASDAQ:OXFD) news were published by: Globenewswire.com which released: “Oxford Immunotec Announces Launch of the Accutixâ„¢ Brand” on May 22, 2018, also Nasdaq.com with their article: “Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress” published on June 04, 2018, Nasdaq.com published: “Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential Diagnostics List” on May 21, 2018. More interesting news about Oxford Immunotec Global PLC (NASDAQ:OXFD) were released by: Globenewswire.com and their article: “Investor Expectations to Drive Momentum within Oxford Immunotec Global, Financial Engines, Brookfield Property …” published on June 05, 2018 as well as Globenewswire.com‘s news article titled: “Oxford Immunotec to Present at the Jefferies 2018 Healthcare Conference” with publication date: May 29, 2018.

Among 4 analysts covering Oxford Immunotec (NASDAQ:OXFD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Oxford Immunotec had 10 analyst reports since July 19, 2017 according to SRatingsIntel. Robert W. Baird maintained Oxford Immunotec Global PLC (NASDAQ:OXFD) on Tuesday, October 31 with “Buy” rating. The rating was maintained by Cowen & Co on Monday, January 22 with “Buy”. Robert W. Baird maintained Oxford Immunotec Global PLC (NASDAQ:OXFD) rating on Thursday, October 19. Robert W. Baird has “Buy” rating and $22.0 target. The stock of Oxford Immunotec Global PLC (NASDAQ:OXFD) earned “Buy” rating by Cowen & Co on Wednesday, July 19. Cowen & Co maintained it with “Buy” rating and $19.0 target in Wednesday, August 16 report. BTIG Research initiated the stock with “Buy” rating in Thursday, September 28 report. Cowen & Co maintained the stock with “Buy” rating in Tuesday, October 31 report. The rating was maintained by Cowen & Co on Wednesday, September 27 with “Buy”. The firm earned “Buy” rating on Monday, January 8 by Piper Jaffray.

Tiverton Asset Management Llc, which manages about $1.44 billion US Long portfolio, upped its stake in Nvidia Corp (NASDAQ:NVDA) by 17,493 shares to 48,375 shares, valued at $11.20M in 2018Q1, according to the filing. It also increased its holding in Fortress Transportation & Infrastructure Investors by 60,000 shares in the quarter, for a total of 180,000 shares, and has risen its stake in Caterpillar Inc (NYSE:CAT).

Analysts await Oxford Immunotec Global PLC (NASDAQ:OXFD) to report earnings on August, 7. They expect $-0.24 EPS, up 25.00% or $0.08 from last year’s $-0.32 per share. After $-0.40 actual EPS reported by Oxford Immunotec Global PLC for the previous quarter, Wall Street now forecasts -40.00% EPS growth.

Investors sentiment decreased to 1.34 in 2018 Q1. Its down 0.23, from 1.57 in 2017Q4. It is negative, as 9 investors sold OXFD shares while 20 reduced holdings. 10 funds opened positions while 29 raised stakes. 23.37 million shares or 2.35% less from 23.93 million shares in 2017Q4 were reported. Ontario – Canada-based Manufacturers Life Company The has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Ellington Mgmt Ltd Limited Liability Company reported 15,900 shares. California State Teachers Retirement has 0% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 39,130 shares. Morgan Stanley reported 54,677 shares. American Gru reported 0% stake. Legal And General Public Ltd has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Quantitative Systematic Strategies Ltd Liability stated it has 0.04% in Oxford Immunotec Global PLC (NASDAQ:OXFD). 5,275 are held by Barclays Public Ltd. 114,083 are owned by Millennium Mngmt Ltd Liability. Blackrock Incorporated reported 0% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). Spark invested 0.08% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Broadfin Capital Ltd Liability Co invested 0.73% of its portfolio in Oxford Immunotec Global PLC (NASDAQ:OXFD). Bank Of America De has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Penn Capital Management Incorporated reported 213,549 shares or 0.21% of all its holdings. Birchview Limited Partnership owns 1.45% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 177,303 shares.

Since February 15, 2018, it had 0 buys, and 2 selling transactions for $74,342 activity.

HD Supply Holdings, Inc. (NASDAQ:HDS) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>